8-K: Nautilus Biotechnology Holds Annual Meeting, Elects Directors

Sentiment:

Annual Meeting of Stockholders


Nautilus Biotechnology, Inc. held its 2026 annual meeting, where stockholders elected Class II directors, ratified the appointment of PricewaterhouseCoopers LLP, and approved executive compensation and the frequency of future advisory votes.

Summary

  • Nautilus Biotechnology, Inc. convened its 2026 annual meeting of stockholders on June 17, 2026.
  • A total of 85,002,191 shares, representing 66.89% of outstanding common stock, were represented.
  • Stockholders elected Parag Mallick and Farzad Nazem as Class II Directors, serving until the 2029 annual meeting.
  • The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026 was ratified.
  • An advisory vote to approve the compensation of named executive officers for fiscal year 2025 received majority support.
  • Stockholders advised that future advisory votes on executive compensation should occur annually.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating smooth execution of standard corporate governance procedures with strong shareholder support for key decisions.

Positives

  • Strong stockholder participation with 66.89% of shares represented at the annual meeting.
  • Unanimous election of Class II Directors Parag Mallick and Farzad Nazem.
  • Overwhelming ratification of PricewaterhouseCoopers LLP as the independent auditor.
  • Majority approval of executive compensation for fiscal year 2025.
  • Clear preference for annual advisory votes on executive compensation, indicating stockholder engagement.

Future Outlook

The company will hold future stockholder advisory votes on executive compensation annually until the next required vote in 2032.

Industry Context

StockSavvy.ai notes that annual meetings and advisory votes on executive compensation are standard corporate governance practices for publicly traded biotechnology companies, reflecting ongoing engagement between management and shareholders.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Class II DirectorN/AParag MallickJune 17, 2026Election by stockholders
Class II DirectorN/AFarzad NazemJune 17, 2026Election by stockholders

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director ElectionElection of Class II Directors Parag Mallick and Farzad Nazem.June 17, 2026Maintains board continuity and expertise.
Auditor RatificationRatification of PricewaterhouseCoopers LLP as independent auditor for FY2026.June 17, 2026Ensures independent financial oversight.
Executive Compensation VoteAdvisory vote to approve executive compensation for FY2025.June 17, 2026Provides shareholder feedback on compensation practices.
Frequency of Say on Pay VoteStockholder vote to determine the frequency of future advisory votes on executive compensation.June 17, 2026Establishes annual advisory votes on executive compensation.

Stakeholder Impact

  • Shareholders: Confirmed director appointments and provided input on executive compensation, reinforcing their governance role.
  • Management: Received advisory approval on executive compensation and confirmation of auditor.
  • Auditors: PricewaterhouseCoopers LLP's appointment for FY2026 was ratified.

Next Steps

  • Class II Directors Parag Mallick and Farzad Nazem will serve until the 2029 annual meeting.
  • PricewaterhouseCoopers LLP will serve as the independent registered public accounting firm for fiscal year 2026.
  • The company will hold annual advisory votes on executive compensation until at least 2032.

Key Dates

DateDescription
April 20, 2026Record date for determining stockholders entitled to vote at the Annual Meeting.
June 17, 2026Date of the 2026 annual meeting of stockholders.
June 18, 2026Date the report was signed.
December 31, 2025Fiscal year end for which executive compensation was voted on.
December 31, 2026Fiscal year for which PricewaterhouseCoopers LLP was appointed as auditor.
2029Term end year for newly elected Class II Directors.
2032Latest date for the next required non-binding advisory vote on the frequency of future Say on Pay Votes.

Keywords

Nautilus Biotechnology, Annual Meeting, Stockholder Vote, Director Election, Executive Compensation, Auditor Ratification, Corporate Governance, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.